UTMC among first hospitals participating in national COVID-19 drug study
Michael Ellis, Md
THE UNIVERSITY OF TOLEDO MEDICAL CENTER is one of the first sites in the country to enroll patients in a National Institutes of Health study aimed at identifying promising COVID-19 treatments worthy of larger, more in-depth clinical trials.
Thursday, March 11, 2021